Open source model in scientific research publising: A revisit to the financial future

Nature has some news to tell the world about their rival PLoS (Public Library of Science). Open source publishing by PLoS thrives on charity funding. Does the business  model needs a redesign of it's aims, goals and strategies? Or is it a cheap trick from scared Nature publishing? Judge yourself....

PLoS stays afloat with bulk publishing : Nature News

The corrupted use of Photoshop in biomedical research

Photoshop might be a "useful" program for many unscrupulous manipulation of research data if it doesn't make sense. Check this out
Researcher suspended for falsifying data : Nature News: "Researcher suspended for falsifying data"

Hopefully no one fell into pit following up with her research finding.
Yet nother disappointing story. Blame it on the tenure track reviews and peer-pressure!

"QSAR: dead or alive?": Journal of Computer-Aided Molecular Design

SpringerLink - Journal Article: "QSAR: dead or alive?"

Another article analysing decline of use of QSAR in drug design. It happens that the previous similar article* also came from Bristol-Myers Squibb.


*http://pubs.acs.org/cgi-bin/abstract.cgi/jcisd8/asap/abs/ci700332k.html

Growth of the Asian health-care market: global implications for the pharmaceutical industry : Nature Reviews Drug Discovery

Growth of the Asian health-care market: global implications for the pharmaceutical industry : Nature Reviews Drug Discovery

The stats says that India is one of the worse in Asia in health care.
Check the graphs at nature drug discovery reviews..